Semax / Selank Nasal

Certificates of analysis

• Batch LLLC490512831 (published 2026-09-11)

See every certificate

Research guides

• Selank: A Research Guide to the Published LiteratureA citation-by-citation overview of published Selank research, covering receptor-level and cell-culture work, rodent behavioural and gene-expression studies, and the small human imaging and clinical literature, with the model system stated for each finding.
• Semax (ACTH(4-7)–Pro-Gly-Pro) in Animal Models of Neurological Injury: A Research SummaryA citation-anchored overview of published animal studies on Semax, a synthetic ACTH(4-10)/ACTH(4-7)-derived peptide, covering rodent models of cerebral ischemia, nitric oxide generation, amnesia, seizure activity, and myocardial infarction. All findings described here were obtained in rats or mice, not in humans.
• Selank as a Tuftsin Analogue: What Animal Studies ReportA research summary of the retrieved animal literature on Selank, a synthetic heptapeptide analogue of the immunopeptide tuftsin, covering inflammation-related gene expression changes in mouse spleen and behavioural and serotonin-metabolism observations in rats.